Evidence map›Paper›PMID 40883979›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Organocatalytic Enantioselective [4 + 4] Cycloadditions of Furan Ortho-Quinodimethanes.

Niklas Lawaetz Østergaard, Anne Kristensen, Enrico Marcantonio, Mette Louise Skipper, Michał Dudziński, David A McLeod, Karl Anker Jørgensen

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Niklas Lawaetz Østergaard *Department of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0000-0001-5586-9991
Anne Kristensen *Department of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0000-0002-8746-7273
Enrico MarcantonioDepartment of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0000-0001-5831-4035
Mette Louise SkipperDepartment of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.
Michał DudzińskiDepartment of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0009-0002-2563-3923
David A McLeodDepartment of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0000-0003-4908-5554
Karl Anker JørgensenDepartment of Chemistry, Aarhus University, Aarhus C, 8000, Denmark.ORCID https://orcid.org/0000-0002-3482-6236

Funding

FNU 2032-00165BNovo Nordisk Foundation NNF 21OC0072047Villum Investigator 25867
6 · The paper itself

Abstract

The enantioselective [4 + 4] cycloaddition for the construction of cyclooctanoids is a challenging transformation in organic chemistry. Herein, we present the first organocatalytic enantioselective [4 + 4] cycloaddition of furan ortho-quinodimethanes, activated by dearomatization of the heteroaromatic compound, which thereby allows for the cycloaddition with dienes. The [4 + 4] cycloaddition is catalyzed by a quinine-derived primary amine in combination with a chiral phosphoric acid and a carboxylic acid affording cyclooctanoids isolated as a single diastereoisomer in good yields and with up to 94% ee. This reaction concept allows for the formation of cyclooctanoids without benzofusion, as demonstrated by oxidative opening of the furan ring. Computational studies of the reaction mechanism for the [4 + 4] cycloaddition point to a stepwise process. Surprisingly, the stereochemical outcome of the reaction is attributed to protonation of the two organocatalyst-bound cyclooctanoid intermediates leading to a preferred set-up for catalyst elimination to account for the absolute configuration of the cyclooctanoid.

Indexed as

Asymmetric synthesisCycloadditionFused‐ring systemsHeterocyclesOrganocatalysis

Identifiers

PMID40883979
PMCPMC12501670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.